SELLAS Life Sciences Group, Inc. (SLS) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は CYTRX CORP 5,093,881 株保有. その他の主要保有者には Stergiou Angelos M. および CICIC DRAGAN.
過去12ヶ月間にインサイダーは 14 件の取引を実施 SLS 株式 — 11 件の買い (評価額 $185.41K) および 0 件の売り (評価額 RSU アワード). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.
SLS インサイダー保有状況
最大保有者
CYTRX CORP
5,093,881 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Cytrx Corp |
10 Percent Owner |
5,093,881 |
2010-07-02 |
|
| 2 |
Stergiou Angelos M. |
President and CEO |
686,966 |
2025-12-05 |
|
| 3 |
Cicic Dragan |
SVP, Chief Development Officer |
557,805 |
2026-01-09 |
|
| 4 |
Burns John Thomas |
CFO |
554,327 |
2026-01-09 |
|
| 5 |
Stergiou Andelos M. |
President and CEO |
450,135 |
2017-12-29 |
|
| 6 |
Mazanet Rosemary |
Chief Medical Officer |
450,000 |
2013-01-31 |
|
| 7 |
Schwartz Mark W. |
President & CEO |
439,978 |
2016-07-06 |
|
| 8 |
Kalin Katherine Bach |
Director |
154,400 |
2026-01-09 |
|
| 9 |
Pavco Pamela |
Other: Former VP Pharma Development |
150,000 |
2011-09-27 |
|
| 10 |
Khvorova Anastasia |
Other: Former CSO |
137,482 |
2011-09-27 |
|
| 11 |
Ahn Mark J |
President & CEO |
116,225 |
2014-07-02 |
|
| 12 |
Kriegsman Steven A |
Director |
100,000 |
2015-06-23 |
|
| 13 |
Beerman Noah D |
CEO and President |
92,994 |
2011-03-17 |
|
| 14 |
Wasman Jane |
Director |
92,900 |
2026-01-09 |
|
| 15 |
Van Nostrand Robert L |
Director |
82,900 |
2026-01-09 |
|
| 16 |
Scheinberg David A |
Director |
73,082 |
2026-01-09 |
|
| 17 |
Varian John |
Director |
72,900 |
2026-01-09 |
|
| 18 |
Hillsberg Sanford |
Director |
56,950 |
2017-10-10 |
|
| 19 |
Gallagher Robert F |
CFO and VP |
50,000 |
2005-03-31 |
|
| 20 |
Kivinski Margaret |
VP and General Counsel |
50,000 |
2015-01-20 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-01-07 |
Kalin Katherine Bach |
Director |
RSU 付与(制限付株式) |
50,000 |
- |
- |
| 2026-01-07 |
Burns John Thomas |
CFO |
RSU 付与(制限付株式) |
300,000 |
- |
- |
| 2026-01-07 |
Cicic Dragan |
SVP, Chief Development Officer |
RSU 付与(制限付株式) |
300,000 |
- |
- |
| 2026-01-07 |
Varian John |
Director |
RSU 付与(制限付株式) |
50,000 |
- |
- |
| 2026-01-07 |
Wasman Jane |
Director |
RSU 付与(制限付株式) |
50,000 |
- |
- |
| 2026-01-07 |
Scheinberg David A |
Director |
RSU 付与(制限付株式) |
50,000 |
- |
- |
| 2026-01-07 |
Van Nostrand Robert L |
Director |
RSU 付与(制限付株式) |
50,000 |
- |
- |
| 2025-12-03 |
Stergiou Angelos M. |
President and CEO |
その他(売り) |
187,066 |
$1.50 |
$280.6K |
| 2025-12-03 |
Burns John Thomas |
CFO |
その他(売り) |
58,592 |
$1.50 |
$87.89K |
| 2025-12-03 |
Cicic Dragan |
SVP, Chief Development Officer |
その他(売り) |
63,800 |
$1.50 |
$95.7K |
| 2025-11-19 |
Kalin Katherine Bach |
Director |
情報に基づく買い |
63,400 |
$1.59 |
$100.81K |
| 2025-06-12 |
Van Nostrand Robert L |
Director |
情報に基づく買い |
10,000 |
$1.48 |
$14.8K |
| 2025-05-30 |
Wasman Jane |
Director |
情報に基づく買い |
20,000 |
$1.69 |
$33.8K |
| 2025-05-22 |
Kalin Katherine Bach |
Director |
情報に基づく買い |
20,000 |
$1.80 |
$36K |